Search

Your search keyword '"Calvo, Inmaculada"' showing total 415 results

Search Constraints

Start Over You searched for: Author "Calvo, Inmaculada" Remove constraint Author: "Calvo, Inmaculada"
415 results on '"Calvo, Inmaculada"'

Search Results

51. Consensus of the Spanish society of pediatric rheumatology for transition management from pediatric to adult care in rheumatic patients with childhood onset

55. Predictors of mental health service utilization as adolescents with attention deficit hyperactivity disorder transition into adulthood

57. Long-term efficacy and safety of canakinumab in patients with mevalonate kinase deficiency: results from the randomised Phase 3 CLUSTER trial

58. OA37 Secukinumab treatment in children and adolescents with enthesitis-related arthritis and juvenile psoriatic arthritis: efficacy and safety results from a Phase 3 study

60. Actas de las IV Jornadas ScienCity 2021. Fomento de la Cultura Científica, Tecnológica y de Innovación en Ciudades Inteligentes

61. Predictors of mental health service utilization as adolescents with attention deficit hyperactivity disorder transition into adulthood.

62. American College of Rheumatology Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents With Childhood-Onset Systemic Lupus Erythematosus

66. Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab

68. Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial

69. Somatic NLRP3 mosaicism in Muckle-Wells syndrome. A genetic mechanism shared by different phenotypes of cryopyrin-associated periodic syndromes

72. Long-term efficacy and safety of canakinumab in patients with mevalonate kinase deficiency: results from the randomised Phase 3 CLUSTER trial

73. Ventricular Repolarization Parameters and Coronary Involvement in Kawasaki Disease

89. Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis

90. Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis

93. GenotypeFBN1/phenotype relationship in a cohort of patients with Marfan syndrome

100. Long-term efficacy and safety of canakinumab in patients with mevalonate kinase deficiency: results from the randomised Phase 3 CLUSTER trial.

Catalog

Books, media, physical & digital resources